Wells Fargo Sticks to Its Sell Rating for Community Health (CYH)
In a report released today, Stephen Baxter from Wells Fargo maintained a Sell rating on Community Health, with a price target of $2.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Baxter is an analyst with an average return of -0.9% and a 43.34% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Community Health, Humana, and Universal Health.
In addition to Wells Fargo, Community Health also received a Sell from Raymond James’s John Ransom in a report issued on February 23. However, on the same day, RBC Capital maintained a Buy rating on Community Health (NYSE: CYH).
Based on Community Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.11 billion and a net profit of $110 million. In comparison, last year the company earned a revenue of $3.27 billion and had a GAAP net loss of $70 million
Read More on CYH:
Disclaimer & DisclosureReport an Issue
- Community Health Divests Four Arkansas Hospitals to Freeman
- Community Health to sell four Arkansas Hospitals to Freeman Health for $112M
- Community Health Systems Earnings Call Shows Cautious Progress
- Community Health price target raised to $3.70 from $3.60 at UBS
- Community Health Advances Portfolio Streamlining and Debt Reduction
